Cold Laser Therapy in St. Louis

Our console delivers four wavelengths, and the reason for using several rather than one is depth and target.

650 nm sits in the visible red range. It is absorbed superficially and is used for tissue at or near the surface.

808 nm is near-infrared and penetrates considerably further, which makes it the workhorse wavelength for structures below the skin — muscle, tendon, and the tissue surrounding peripheral nerves.

905 nm is typically delivered in very short, high-intensity pulses. Pulsing allows high peak power without accumulating heat, which is useful for reaching deeper tissue.

980 nm is absorbed more strongly by water and by tissue generally, producing a gentle thermal effect alongside the photochemical one. That helps with local circulation and muscle relaxation.

A single wavelength is always a compromise. Using several allows treatment to be matched to the depth and type of tissue involved rather than applying the same light to every problem.

The mechanism most widely accepted is absorption by cytochrome c oxidase, an enzyme in the mitochondrial respiratory chain. Red and near-infrared light in this range is absorbed by that enzyme, and the effect is to improve mitochondrial efficiency — more usable energy produced from the same substrate.

Two secondary effects follow. Nitric oxide that had been inhibiting the enzyme is displaced, which locally improves blood flow. And there is a brief, modest rise in reactive oxygen species which acts as a signal rather than as damage, triggering repair and anti-inflammatory pathways.

This is also why the response is not proportional to dose the way a drug is. Too little light does nothing; too much can suppress the response rather than amplify it. That biphasic dose relationship is the reason parameters matter more than raw intensity, and why a clinical device is not interchangeable with a consumer one.

Photobiomodulation is used here where inflammation, impaired healing, or peripheral nerve involvement forms part of the clinical picture:

• Neuropathic pain, including diabetic neuropathy
• Tendon and soft-tissue injury that has not resolved with rest or rehabilitation
• Persistent inflammation around a joint or a peripheral nerve
• Supporting recovery between interventional procedures
• As one component of broader work on metabolic inflammation, where systemic inflammatory load is driving symptoms

Where nerve involvement is suspected we generally establish it objectively first with electrodiagnostic testing, so that treatment is aimed at a confirmed problem rather than a presumed one.

Sessions are short, typically several minutes per treated area. The handpiece is applied directly to the skin over the target tissue. Most patients feel nothing at all; at 980 nm some notice mild warmth.

There is no preparation and no downtime. You can drive yourself, return to work immediately, and there are no activity restrictions afterwards. Protective eyewear is worn during treatment.

Photobiomodulation is cumulative rather than immediate. A single session rarely produces a lasting change; a course delivered over several weeks is the usual approach, with the interval and number determined by what is being treated and how you respond.

We would rather set expectations accurately than oversell this.

Photobiomodulation does not replace identifying the source of your pain. If a nerve root is compressed or a joint is arthritic, light does not change the mechanics, and treating the region without establishing the generator is how patients end up spending months on therapy that was never going to work.

The evidence base is also uneven. It is stronger for some indications — certain soft-tissue and wound-healing applications — than for others, where it remains an area of active investigation. We will tell you which category your indication falls into.

It is likewise not the same as a consumer red-light panel. Wavelength, power density and delivery time determine whether anything useful happens at the tissue depth you need, and a device designed for skin does not reach a structure several centimeters down.

Of everything photobiomodulation is used for, peripheral neuropathy is the indication we are asked about most, and it is worth being precise about what is and is not plausible.

In diabetic and other metabolic neuropathies, the damage is not only to the nerve fiber itself. The small blood vessels supplying the nerve — the vasa nervorum — are compromised, and the nerve is starved of the perfusion it needs to maintain and repair itself. That microvascular component is the part photobiomodulation is most plausibly acting on: improved local blood flow through nitric oxide release, and improved mitochondrial function in tissue that is energy-starved.

What that means practically is that photobiomodulation is aimed at the environment the nerve is trying to survive in, not at reversing established structural damage. Fibers that have already died do not come back. Where symptoms are driven by an ischemic and inflammatory environment around surviving fibers, there is a reasonable mechanistic case for treating it.

It also means the therapy does very little on its own if the metabolic driver is untouched. Sustained high blood sugar will continue damaging the nerve faster than any light can support its repair, which is why we treat neuropathy as a metabolic problem and a nerve problem at the same time.

We start by establishing what is actually generating your symptoms. For suspected nerve involvement that usually means electrodiagnostic testing to confirm whether a nerve is affected, where, and how severely. Treating a presumed neuropathy that turns out to be referred pain from the lumbar spine wastes months.

From there the question is whether inflammation, perfusion or impaired healing is a meaningful part of the picture. Where it is, photobiomodulation has a mechanistic rationale and is worth a defined trial. Where the dominant problem is mechanical — a compressed nerve root, an arthritic joint, an unstable segment — the honest answer is that light will not change the mechanics, and we would rather say so than sell you a course of treatment.

We also set a review point in advance. A defined number of sessions, then an honest reassessment of whether anything measurable has changed. Open-ended treatment with no checkpoint is how patients end up months into something that was never working.